Elicio Therapeutics, Inc. financial data

Symbol
ELTX on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 234% % 11%
Debt-to-equity 591% %
Return On Equity -978% % -228%
Return On Assets -142% % 27%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,396,074 shares 15%
Common Stock, Shares, Outstanding 17,800,307 shares 61%
Entity Public Float $81,800,000 USD 146%
Common Stock, Value, Issued $178,000 USD 62%
Weighted Average Number of Shares Outstanding, Basic 15,312,751 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 15,312,751 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $24,903,000 USD -26%
General and Administrative Expense $12,811,000 USD 13%
Costs and Expenses $37,714,000 USD -16%
Operating Income (Loss) $37,714,000 USD 16%
Nonoperating Income (Expense) $1,857,000 USD 73%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $39,571,000 USD 24%
Earnings Per Share, Basic -2.58 USD/shares 39%
Earnings Per Share, Diluted -2.58 USD/shares 39%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $18,563,000 USD 5.4%
Assets, Current $19,311,000 USD -6.7%
Property, Plant and Equipment, Net $295,000 USD -39%
Operating Lease, Right-of-Use Asset $4,782,000 USD -16%
Assets $25,862,000 USD -8.2%
Accounts Payable, Current $672,000 USD -35%
Employee-related Liabilities, Current $2,528,000 USD 9.3%
Accrued Liabilities, Current $6,427,000 USD -24%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $8,110,000 USD -30%
Operating Lease, Liability, Noncurrent $4,094,000 USD -20%
Liabilities $24,226,000 USD -39%
Accumulated Other Comprehensive Income (Loss), Net of Tax $127,000 USD 27%
Retained Earnings (Accumulated Deficit) $233,672,000 USD -20%
Stockholders' Equity Attributable to Parent $1,636,000 USD
Liabilities and Equity $25,862,000 USD -8.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,119,000 USD 17%
Net Cash Provided by (Used in) Financing Activities $10,328,000 USD -6.3%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 17,814,762 shares 61%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $240,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19,267,000 USD -1.2%
Deferred Tax Assets, Valuation Allowance $110,304,000 USD 10%
Operating Lease, Liability $5,105,000 USD -15%
Depreciation $204,000 USD -36%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $39,523,000 USD 24%
Lessee, Operating Lease, Liability, to be Paid $6,040,000 USD -18%
Property, Plant and Equipment, Gross $2,051,000 USD 0.79%
Operating Lease, Liability, Current $1,011,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,425,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,383,000 USD 2.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $935,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,467,000 USD 2.9%
Deferred Tax Assets, Operating Loss Carryforwards $77,260,000 USD 20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $4,141,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,512,000 USD 3.1%
Operating Lease, Payments $334,000 USD -12%
Additional Paid in Capital $235,407,000 USD 29%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $2,697,000 USD 86%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%